Eloctate with Fc Fusion Protein recombinant and Oncaspar
Determining the interaction of Eloctate with Fc Fusion Protein recombinant and Oncaspar and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Eloctate with Fc Fusion Protein (recombinant), Eloctate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eloctate with Fc Fusion Protein recombinant-Oncovin
- Eloctate with Fc Fusion Protein recombinant-Ondansetron
- Eloctate with Fc Fusion Protein recombinant-Ondansetron and Dextrose
- Eloctate with Fc Fusion Protein recombinant-Ondansetron Hydrochloride
- Eloctate with Fc Fusion Protein recombinant-Ondansetron injection
- Eloctate with Fc Fusion Protein recombinant-Ondansetron ODT
- Oncaspar-Elotuzumab
- Oncaspar-Elotuzumab Intravenous
- Oncaspar-Eloxatin
- Oncaspar-Elppa CoQ10 coenzyme Q-10
- Oncaspar-Elspar
- Oncaspar-Elta SilverGel